Compare MDGL & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | LPX |
|---|---|---|
| Founded | 2011 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 5.6B |
| IPO Year | N/A | N/A |
| Metric | MDGL | LPX |
|---|---|---|
| Price | $585.68 | $80.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $580.77 | $109.14 |
| AVG Volume (30 Days) | 268.0K | ★ 926.4K |
| Earning Date | 11-04-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.02 |
| Revenue | $740,640,000.00 | ★ $2,821,000,000.00 |
| Revenue This Year | $435.63 | N/A |
| Revenue Next Year | $52.56 | $5.89 |
| P/E Ratio | ★ N/A | $26.74 |
| Revenue Growth | ★ 864.21 | N/A |
| 52 Week Low | $265.00 | $73.42 |
| 52 Week High | $615.00 | $119.91 |
| Indicator | MDGL | LPX |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 42.71 |
| Support Level | $578.00 | $79.01 |
| Resistance Level | $615.00 | $83.16 |
| Average True Range (ATR) | 19.08 | 1.80 |
| MACD | -1.59 | -0.35 |
| Stochastic Oscillator | 63.20 | 18.16 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.